RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$913M
AUM Growth
+$115M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
108
New
Increased
Reduced
Closed

Top Buys

1
+$9.4M
2
+$9.14M
3
+$7.09M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.8M
5
COO icon
Cooper Companies
COO
+$6.43M

Top Sells

1
+$12.1M
2
+$12M
3
+$11.5M
4
TMO icon
Thermo Fisher Scientific
TMO
+$11.1M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$9.05M

Sector Composition

1 Healthcare 93.54%
2 Financials 0.09%
3 Energy 0.09%
4 Technology 0.09%
5 Communication Services 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$3.17M 0.35%
750,000
+114,566
77
$3.07M 0.34%
+75,000
78
$2.48M 0.27%
+144,604
79
$2.45M 0.27%
+80,000
80
$1.6M 0.18%
200,000
81
$1.09M 0.12%
3,750
82
$358K 0.04%
2,974
83
$301K 0.03%
2,083
84
$299K 0.03%
3,391
85
$297K 0.03%
2,317
86
$292K 0.03%
2,095
-377
87
$284K 0.03%
5,272
88
$271K 0.03%
29,164
89
$269K 0.03%
3,854
90
$260K 0.03%
10,645
91
$230K 0.03%
2,806
-603
92
$224K 0.02%
8,761
93
$214K 0.02%
+3,200
94
$203K 0.02%
+8,299
95
– –
-290,000
96
– –
-99,000
97
– –
-320,000
98
– –
-30,000
99
– –
-1,532
100
– –
-38,000
1 2 3
4
5